Remove about
Remove Access Remove Cannabis Remove Data Remove Information
article thumbnail

Illinois releases Cannabis Report FY2024 (IDFPR portion)

Illinois News Joint

Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Find detailed information about this topic here.)

article thumbnail

IDOA announces Metrc implementation timeline

Illinois News Joint

The Illinois Department of Agriculture (IDOA) and the Division of Cannabis Regulation announced today an official Metrc implementation timeline for licensed cannabis businesses transitioning from BioTrack to Metrc as Illinois’ track-and-trace data system. Metrc has additional information and support available online here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The History of RSO: One Man’s Journey Changed Everything

LifeCannMD

This isn’t a story about recreational marijuana or getting high. It’s about a regular guy with no medical background who was just trying to feel better. Desperate for relief, he remembered something he’d heard about medical marijuana. Rick still couldn’t find a doctor willing to support his cannabis use.

History 82
article thumbnail

A Look at the Cannabis Marketing Sector

CannaEffect

The Ups and Downs of a Booming Industry In recent years, the cannabis sector has undergone a spectacular transition as a result of the wave of legalization that has swept across numerous places all over the world. This shift in legal and social attitudes has given rise to a booming cannabis market.

article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

Drug company Lykos Therapeutics, which had filed the new drug application for MDMA therapy , was informed by the US Food and Drug Administration (FDA) that the data submitted was insufficient to receive approval, requesting that the company conduct an additional Phase 3 trial to further test the safety and efficacy of the drug.

article thumbnail

Participate in a Confidential Survey Assessing Cannabis Use Patterns During the COVID-19 Pandemic

NORML

A team of researchers affiliated with the University of Miami School of Nursing are collecting epidemiological data to better evaluate how cannabis consumers, and patients in particular, are responding to the COVID-19 pandemic. So, we are combining our skills to do our part to provide that data. Vidot, who is leading the study.

Data 286
article thumbnail

Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent

NORML

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings. ” — appears online here.

CBD 296